PRESTIGE BIOPHARMA 프레스티지바이오파마 Prestigebiopharma

Innovation for Life

Developing Innovative drugs, Biosimilars, Platforms, and Diagnostic technologies to improve lives.

Advancing Antibody Science

Advancing antibody drugs and biosimilars to address unmet medical needs.

Creating Value for a Healthier Life

Improving patient access through cost-effective, high-quality biosimilars.

PRESTIGE BIOPHARMA

PRESTIGE BIOPHARMA IDC

PRESTIGE BIOLOGICS

7

Beyond technological discovery, expanding access to care for patients around the world

Innovative Drug

Development of First-in-Class therapeutics for unmet diseases

Biosimilar

Prominent Biosimilars pipelines for accelerating market access

Platform Technology

A drug delivery platform that enhances treatment convenience

Diagnostics

Diagnostics for Pancreatic cancer by detecting PAUF

Prestige News

Total 78

Number	Thumbnail	Title	Author	Date	Votes	Views
78		Prestige Biopharma IDC's Taeheung Kang, Director of Drug Development Division: 'Additional Pipelines Ready… Accelerating Resear 김** \| 2026.10.01 \| Votes 0 \| Views 314	김**	2026.10.01	0	314
77		Prestige Biopharma Appoints Neil O’Connor as Board Director, Strengthening Expertise in CMC and Quality Management 김** \| 2026.09.30 \| Votes 0 \| Views 266	김**	2026.09.30	0	266
76		Prestige Biopharma Receives Brazilian Marketing Authorization for Herceptin Biosimilar Tuznue 김** \| 2026.09.28 \| Votes 0 \| Views 518	김**	2026.09.28	0	518
75		Prestige Biopharma’s Tuznue Receives Marketing Authorization in Trinidad and Tobago 김** \| 2026.09.18 \| Votes 0 \| Views 755	김**	2026.09.18	0	755
74		Prestige Biopharma IDC Obtains ISO 14001 and ISO 45001 Certifications 김** \| 2026.09.17 \| Votes 0 \| Views 544	김**	2026.09.17	0	544
73		Prestige Biopharma Successfully Concludes ‘Prestige Symposium’ on Aging 김** \| 2026.09.09 \| Votes 0 \| Views 1143	김**	2026.09.09	0	1143
72		Prestige Biopharma IDC CEO Ko Sang-seok Purchases Company Shares on the Open Market 김** \| 2026.09.03 \| Votes 0 \| Views 1377	김**	2026.09.03	0	1377
71		Prestige Biopharma’s Tuznue Secures Brazilian GMP Certification, Supporting Latin American Approval Process 김** \| 2026.08.25 \| Votes 0 \| Views 2038	김**	2026.08.25	0	2038
70		Prestige Biopharma Files Patent Application for TASA™, a Blood-Based Pancreatic Cancer Diagnostic Platform 김** \| 2026.08.12 \| Votes 0 \| Views 2066	김**	2026.08.12	0	2066
69		Prestige Biopharma Positions PBP1710 as Its Next-Generation Growth Driver 김** \| 2026.08.11 \| Votes 0 \| Views 2586	김**	2026.08.11	0	2586

Read Prestige news >>